← Browse by Condition
Medical Condition
respiratory tract neoplasms
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2
ClinicalMetric tracks all active clinical trials for respiratory tract neoplasms sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 2 2
Top Sponsors
2 trials
1 trial
NCT06004440
Recruiting
Real World Registry for Use of the Ion Endoluminal System
Enrollment
3,000 pts
Location
United States
Sponsor
Intuitive Surgical
NCT07242547 Phase 2
Recruiting
Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients
Enrollment
37 pts
Location
Spain
Sponsor
Fundación GECP
NCT06917573 Phase 2
Recruiting
PALACE: Cemiplimab Trial According to ctDNA Levels
Enrollment
63 pts
Location
Spain
Sponsor
Fundación GECP